- ISIN
- US03475V1017
- CUSIP
- 03475V101
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- May 27, 2004
Highlights
- Market Cap
- $611.31M
- Enterprise Value
- $557.44M
- EPS (TTM)
- -$0.89
- Total Revenue (TTM)
- $320.17M
- Gross Profit (TTM)
- $174.89M
- EBITDA (TTM)
- -$36.00M
- Year Range
- $8.36 - $15.20
- Target Price
- $16.50
- ROA (TTM)
- -13.75%
- ROE (TTM)
- -21.51%
- Avg. Volume (1M)
- 549K
- Avg. Volume Value (1M)
- $7.52M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ANGO Performance Chart
AngioDynamics, Inc. (ANGO) is up 15.2% since the beginning of the year. At $15 per share, ANGO is trading just below its 52-week high of $15. Investors who bought $1,000 worth of ANGO shares 5 years ago would now be looking at an investment worth $555.
Loading charts...
Compare this symbol against anything
Returns By Period
AngioDynamics, Inc. (ANGO) has returned 15.19% so far this year and 72.78% over the past 12 months. Over the last ten years, ANGO has returned -0.34% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
AngioDynamics, Inc.
- 1D
- 0.14%
- 1M
- 12.99%
- 6M
- 42.76%
- YTD
- 15.19%
- 1Y
- 72.78%
- 3Y*
- 19.81%
- 5Y*
- -11.10%
- 10Y*
- -0.34%
- ALL TIME*
- 0.19%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
ANGO Monthly Returns History
Based on dividend-adjusted daily data since Jun 1, 2004, ANGO's average daily return is +0.04%, while the average monthly return is +0.69%. At this rate, an investment would double in approximately 8.4 years.
Historically, 49% of months were positive and 51% were negative. The best month was Nov 2004 with a return of +74.9%, while the worst month was Oct 2022 at -31.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ANGO closed higher 49% of trading days. The best single day was Jan 8, 2025 with a return of +37.7%, while the worst single day was Mar 7, 2008 at -37.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.31% | 10.42% | -0.61% | -3.78% | 4.94% | 13.33% | 13.68% | 15.19% | |||||
| 2025 | 24.56% | -18.58% | 1.08% | -1.06% | 9.80% | -2.75% | -10.69% | 15.80% | 8.87% | 7.70% | 3.08% | 3.55% | 40.17% |
| 2024 | -24.74% | -6.95% | 6.92% | -1.36% | 8.98% | -4.12% | 29.59% | -4.85% | 4.29% | -14.01% | 3.59% | 32.18% | 16.84% |
| 2023 | -5.45% | -4.92% | -16.48% | -19.54% | 13.70% | 10.25% | -16.68% | -7.59% | -8.97% | -15.18% | 5.32% | 20.06% | -43.06% |
| 2022 | -21.57% | 8.78% | -8.46% | -2.27% | -6.75% | -1.43% | 17.26% | -2.42% | -7.59% | -31.13% | -8.09% | 6.33% | -50.07% |
| 2021 | 22.24% | 11.79% | 11.69% | 3.85% | -4.86% | 17.34% | -1.84% | 6.27% | -8.34% | 10.25% | -9.97% | 7.11% | 79.91% |
Benchmark Metrics
AngioDynamics, Inc. has an annualized alpha of 1.30%, beta of 0.93, and R2 of 0.14 versus S&P 500 Index. Calculated based on daily prices since June 01, 2004.
- This stock participated in 90.09% of S&P 500 Index downside but only 52.95% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.14 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1.30%
- Beta
- 0.93
- R²
- 0.14
- Upside Capture
- 52.95%
- Downside Capture
- 90.09%
Return for Risk
Risk / Return Rank
ANGO ranks 82 for risk / return — above 82% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for AngioDynamics, Inc. (ANGO) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANGO | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.25 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.33 | 2.00 | +0.33 |
| Martin ratioReturn relative to average drawdown | 4.87 | 8.49 | -3.62 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the AngioDynamics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AngioDynamics, Inc. was 83.04%, occurring on Mar 25, 2024. The portfolio has not yet recovered.
The current AngioDynamics, Inc. drawdown is 52.40%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-83.04%Mar 2024 | 17y 11mo | — | 20y 3moMay 2006 - now | — |
-39.87%Oct 2004 | 3mo 23d | 1mo 6d | 4mo 29dJun 2004 - Nov 2004 | — |
-32.65%Apr 2005 | 3mo 8d | 2mo 24d | 6mo 2dJan 2005 - Jul 2005 | — |
-29.08%Oct 2005 | 2mo 25d | 2mo 26d | 5mo 21dJul 2005 - Jan 2006 | — |
-25.69%Mar 2006 | 1mo 15d | 18d | 2mo 3dJan 2006 - Mar 2006 | — |
Drawdown Indicators
| ANGO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.04% | -56.78% | -26.26% |
Max Drawdown (1Y)Largest decline over 1 year | -28.89% | -9.10% | -19.79% |
Max Drawdown (3Y)Largest decline over 3 years | -40.65% | -18.90% | -21.75% |
Max Drawdown (5Y)Largest decline over 5 years | -82.98% | -25.43% | -57.55% |
Max Drawdown (10Y)Largest decline over 10 years | -82.98% | -33.92% | -49.06% |
Current DrawdownCurrent decline from peak | -52.40% | -1.58% | -50.82% |
Average DrawdownAverage peak-to-trough decline | -47.87% | -10.70% | -37.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.79% | 2.14% | +11.65% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of AngioDynamics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how AngioDynamics, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ANGO relative to other companies in the Medical Instruments & Supplies industry. Currently, ANGO has a P/S ratio of 1.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ANGO in comparison with other companies in the Medical Instruments & Supplies industry. Currently, ANGO has a P/B value of 3.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ANGO
Add AngioDynamics, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ANGO